Low LDL-C Levels: Likely No Short-Term Cognitive Harm

J Am Coll Cardiol. 2020 May 12;75(18):2294-2296. doi: 10.1016/j.jacc.2020.03.040.
No abstract available

Keywords: PCSK9 inhibitor; cholesterol; cognition; lipid-lowering therapies; safety; statin.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Cholesterol, LDL
  • Cognition
  • Proprotein Convertase 9*

Substances

  • Antibodies, Monoclonal, Humanized
  • Cholesterol, LDL
  • Proprotein Convertase 9
  • evolocumab